Moxifloxacin Micro Labs (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Moxifloxacin Micro Labs, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial infections of the eye, including conjunctivitis and keratitis, in adult patients. GNH USA supplies Moxifloxacin Micro Labs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used to manage bacterial eye infections. - Bacterial conjunctivitis: reduces bacterial load and resolves infection of the conjunctiva. - Bacterial keratitis: eradicates pathogenic bacteria in the cornea, promoting healing and preserving vision. - Post‑surgical prophylaxis: prevents bacterial contamination after ocular surgery, supporting a sterile healing environment.

Moxifloxacin may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Blurred vision: temporary visual disturbance after dosing. - Tearing: increased lacrimation. - Foreign body sensation: feeling of grit in the eye. - Photophobia: heightened sensitivity to light.

Serious or Rare Side Effects: - Corneal ulceration: severe corneal damage requiring immediate attention. - Allergic reaction: swelling, itching, or rash around the eye. - Stevens‑Johnson syndrome: rare but life‑threatening mucocutaneous reaction. - Severe ocular inflammation: marked swelling or pain. - Vision loss: abrupt decrease in visual acuity. - Anaphylaxis: systemic allergic response, though extremely uncommon.

Moxifloxacin should be used with caution in specific patient groups and clinical situations. - Pregnancy: safety not established; avoid unless clearly needed. - Breastfeeding: unknown excretion in milk; consider risk‑benefit. - Pediatric use: not recommended for children without specialist guidance. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Contact lens wearers: remove lenses before administration and re‑insert after adequate interval. - Store at room temperature: keep in original container, protect from light and moisture.

Moxifloxacin may interact with other ophthalmic or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Co‑administration with other quinolone eye drops: increased risk of ocular toxicity. - Systemic fluoroquinolones: additive tendon‑rupture risk, especially in elderly. - Topical NSAIDs: may exacerbate corneal epithelial damage.

Moderate Interactions (Monitor Closely): - Corticosteroid eye drops: heightened risk of secondary infection. - Anticholinergic eye drops: possible reduction in drug absorption. - Contact lens cleaning solutions: may cause irritation when used together.